+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
ID07270237

Development and Evaluation of Ultrasound Imaging Acquisition and Analysis Methods for Pancreatic Cancer and Thyroid Nodules

Led by Memorial Sloan Kettering Cancer Center · Updated on 2025-12-12

85

Participants Needed

7

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating how well multiparametric ultrasound mpUS imaging can examine and provide information about cancerous and non-cancerous tissues. This study compares mpUS, which combines different ultrasound methods to show detailed tissue structure and blood flow, with standard ultrasound and other tests. The goal is to see if mpUS can offer a more accurate assessment, especially for pancreatic cancer and thyroid nodules. Participants will receive additional mpUS imaging during their standard ultrasound procedures, which adds about 5 to 15 minutes of scan time. There are three groups patients at high risk for pancreatic cancer undergoing endoscopic ultrasound, patients with pancreatic ductal adenocarcinoma receiving endoscopic ultrasound-guided biopsies, and patients having thyroid nodule biopsies. Healthy volunteers without cancer or thyroid nodules may also join. During the study, participants will undergo mpUS imaging alongside their usual care scans. Researchers will collect the extra ultrasound data to evaluate the feasibility of mpUS imaging. The main outcome is assessing how well mpUS works during the imaging procedures. This study is non-randomized, has no masking, and will continue until November 2027. Participants may be followed up as agreed, and the total added scan time is brief.

CONDITIONS

Brief Title

A Study of Multiparametric Ultrasound Imaging Methods

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Be at least 50 years old if at high risk for pancreatic cancer, or at least 40 years old if diagnosed with certain genetic syndromes related to pancreatic cancer
  • Be at least 35 years old if diagnosed with Peutz-Jeghers syndrome
  • Not pregnant and not nursing
  • For high-risk pancreatic cancer group: meet specific family history or genetic testing criteria as defined by the study
  • For pancreatic ductal adenocarcinoma group: patients undergoing endoscopic ultrasound-guided biopsy
  • For thyroid nodule group: patients undergoing ultrasound-guided thyroid biopsy
  • Healthy volunteers must be 18 years or older, have no known cancer or thyroid nodules, and be able to give informed consent
Not Eligible

You will not qualify if you...

  • Under 18 years of age
  • Unable to sign informed consent for medical or other reasons
  • Residents outside the continental United States (for pancreatic ductal adenocarcinoma and thyroid nodule groups)
  • Pregnant or nursing individuals (implied by inclusion requirements)

Research Team

M

Mark T Burgess, PhD

W

Wyanne Law, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here